NICOLE DIDONATO: Open Payments
NPI 1760909436 · BELOIT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 112 payments from 19 companies in 2025. Trend: 2023 $2,272 · 2024 $2,430 · 2025 $2,409
Food & beverage: $2,209Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $438 |
| Janssen Biotech, Inc. | 20 | $410 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $240 |
| GENZYME CORPORATION | 4 | $194 |
| Galderma Laboratories, L.P. | 10 | $145 |
| Regeneron Healthcare Solutions, Inc. | 8 | $138 |
| PFIZER INC. | 6 | $131 |
| Lilly USA, LLC | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Biofrontera Inc. | 1 | $87 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, EBGLYSS, ILUMYA, NEMLUVIO.
Industry payments across OH — which companies pay providers there.
